Primary Site >> Colorectal Cancer
Gene >> EPHB4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. PMID: 8761303 |
Ref: Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. PMID: 11801186 |
Ref: Coexpression of ephrin-Bs and their receptors in colon carcinoma. PMID: 11920461 |
Ref: Inhibition of tumor growth and angiogenesis by soluble EphB4. PMID: 15153337 |
Ref: EPHB4 and survival of colorectal cancer patients. PMID: 16982731 |
Ref: The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers. PMID: 18281782 |
Ref: Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. PMID: 19366806 Ref: Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. PMID: 19483190 Ref: The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis. PMID: 19738063 |
Ref: Combining modularity, conservation, and interactions of proteins significantly increases precision and coverage of protein function prediction. PMID: 21171995 |
Ref: Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer. PMID: 21393996 |
Ref: Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis. PMID: 21852108 |
Ref: Targeting the EphB4 receptor for cancer diagnosis and therapy monitoring. PMID: 23211050 Ref: Detection of cadherin-17 in human colon cancer LIM1215 cell secretome and tumour xenograft-derived interstitial fluid and plasma. PMID: 23557862 Ref: Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab. PMID: 23579861 Ref: PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies. PMID: 23667241 |
Ref: EPHB4 tyrosine-kinase receptor expression and biological significance in soft tissue sarcoma. PMID: 25274141 |
Ref: Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers. PMID: 26414866 Ref: EphB4 promotes the proliferation, invasion, and angiogenesis of human colorectal cancer. PMID: 27072105 Ref: KSR1 and EPHB4 Regulate Myc and PGC1beta To Promote Survival of Human Colon Tumors. PMID: 27273865 |
Ref: Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery. PMID: 28165374 Ref: Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. PMID: 28598398 Ref: Near infrared light mediated photochemotherapy for efficiently treating deep orthotopic tumors guided by ultrasound imaging. PMID: 28942682 |
Ref: Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and composition. PMID: 29368976 Ref: Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study. PMID: 29636300 |